MID-ATLANTIC GROUP
70 COLONY RD W
November 14, 2017
This peer-to-peer exchange highlights results of a study that tested whether analyzing circulating tumor DNA (ctDNA) during treatment with chemoradiotherapy could predict outcomes in patients with localized lung cancer.